Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Thrombocytopenia
Questions discussed in this category
How do you approach anticoagulation in the setting of HIT and thrombocytopenia?
i.e. platelet count <30. Would your management change if HIT were only suspected rather than confirmed?
1 Answer available
At what platelet count would you feel comfortable dosing aspirin 81 mg for coronary artery disease in a patient with ITP?
Presuming strong indication for ASA - eg history of NSTEMI
1 Answer available
To what extent does the degree of thrombocytopenia correlate with the severity of cirrhosis?
1 Answer available
Based on recent data would you consider adding ATRA to low dose rituximab for steroid refractory ITP?
https://doi.org/10.1182/blood.2021013393
1 Answer available
Would you give a TPO agonist for thrombocytopenia in alcoholic cirrhosis?
1 Answer available
How do you approach very treatment-refractory ITP?
Such as the case in which a patient is unresponsive to steroids, IVIG, TPO-agonist, rituximab, splenectomy, and even fostamitinib.
1 Answer available
How do you manage drug-induced thrombocytopenia when the implicated drug is essential?
e.g. DITP from eptifibatide after a cardiac intervention
1 Answer available
For treatment of ITP, what would you add to dexamethasone to achieve the fastest recovery in a patient waiting for a procedure?
IVIG, TPO, or other agents?
1 Answer available
Do you routinely check platelet counts after COVID-19 vaccines in patients with chronic ITP?
1 Answer available
With what agents can you replace PPIs if they cause thrombocytopenia?
1 Answer available
Should platelet transfusions be considered for anti-platelet agent reversal in patients with major bleeding?
1 Answer available
How long do you continue caplacizumab in relapsed refractory TTP?
How often do you monitor ADAMTS-13 levels off therapy?
1 Answer available
Are there any reasons to consider a prolonged course of steroids with taper over a shorter course of pulsed steroids in the treatment of ITP?
For example, do we prefer one regimen over the other in patients with a bleeding history or who have relapsed after a lengthy remission?
1 Answer available
How do you approach the treatment of drug-induced thrombotic microangiopathy?
When do you consider initiating eculizumab?
1 Answer available
What is your approach to platelet transfusion in heparin induced thrombocytopenia?
Does having a concurrent consumptive process e.g. DIC change your management?
1 Answer available
How would you advise patients with known stable autoimmune thrombocytopenia regarding the Ad26.COV2.S (Johnson & Johnson/Janssen) vaccine?
1 Answer available
When (if ever) do you check for anti-platelet antibodies for workup of thrombocytopenia?
1 Answer available
Is there a role for prophylactic tranexamic acid in patients with hematologic malignancy with chemotherapy-induced thrombocytopenia?
1 Answer available
How do you approach the treatment of ITP in a pregnant patient who did not respond to prednisone?
Would you consider high-dose dexamethasone (deliberating adverse effects of antenatal steroids) or move to next-line therapies?
1 Answer available
What is your approach to treating refractory thrombocytopenia in lupus?
2 Answers available
How do you manage thrombocytopenia when radiating the spleen?
At what point would you recommend transfusion? At what point would you stop radiation?
1 Answer available
When should you use caplacizumab in the treatment of acute TTP patients?
1 Answer available
13300
10957
12751
12597
12346
8610
11975
11798
9759
10363
8566
10179
8606
9948
9890
9779
9696
9387
9345
8587
7647
7520
Papers discussed in this category
Blood, 2015 May 13
A novel triple therapy for ITP using high-dose dexamethasone, low-dose rituximab, and cyclosporine (TT4).
Blood, 2009 Nov 06
Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura.
Blood,
Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance.
J Pharm Pract, 2019 Mar 27
Lansoprazole-Induced Thrombocytopenia in a Critically Ill Patient: A Case Report.
Related Topics
Hematology
Benign Hematology
Medical Oncology
ITP
Pediatric Oncology
Pediatric Hematology
Hemostasis/Thrombosis
Rheumatology
Liver disease
Neurology